Search clinical trials for: [68Ga]-NeoB

Total 873 results

St Vincent's Hospital, Sydney
Novartis

Recruiting

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Breast Cancer

Australia
Peking Union Medical College Hospital

Unknown

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Lymphatic Disorders

China
Novartis Pharmaceuticals

Recruiting

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. (NeoB-Cap1)

Breast Cancer

United States, Korea, Republic of, Spain, Canada, France, Germany, Italy, Portugal, China, Australia, United Kingdom, Singapore
Novartis Pharmaceuticals

Recruiting

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Newly Diagnosed and Recurrent Glioblastoma

United States, Germany, Spain, Israel, Italy, Portugal, France
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Completed

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

Lymphedema | Hemangioma | Arteriovenous Malformation | Neoplasms Lymph Nodes

China
Novartis Pharmaceuticals

Recruiting

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Breast Cancer

United States, Germany, France, Spain, Portugal, China, Poland
Advanced Accelerator Applications

Active, not recruiting

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake (NeoRay)

Neoplasms

United States, Netherlands, France, Austria, Spain, United Kingdom
Symetis SA

Completed

ACURATE Neo™ AS Aortic Bioprosthesis for Implantation Using the ACURATE neoTM AS TF Transfemoral Delivery System in Patients With Severe Aortic Stenosis

Aortic Stenosis

Germany, Denmark, Switzerland
Novartis Pharmaceuticals

Recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer

United States, Spain, United Kingdom, Italy, France
Peking Union Medical College Hospital

Recruiting

68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma

Multiple Myeloma

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

Medullary Thyroid Carcinoma

China
Peking Union Medical College Hospital

Recruiting

Application of 68Ga-Pentixafor PET/CT for Thymoma

Thymoma

China
Pentixapharm AG

Terminated

[68Ga]Ga-PentixaFor PET Imaging in CNS Lymphoma Patients

CNS Lymphoma

Denmark, France
Peking University Cancer Hospital & Institute
Peking University Health Science Center

Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Cancer

China
Xiangya Hospital of Central South University

Completed

Clinical Translation of a Novel FAPI Dimer [68Ga]Ga-LNC1013

Gastrointestinal Cancer

China
Yusuf Menda
National Cancer Institute (NCI); National Institutes of Health (NIH); Holden...

Active, not recruiting

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
First Affiliated Hospital of Fujian Medical University

Completed

A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study

Tumor Positron-Emission Tomography

China
Ipsen

Terminated

Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer

Austria
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI PET/MR for Atherosclerosis

Atherosclerosis

China
Peking Union Medical College Hospital

Recruiting

Characterizing IgG4-RD With 68Ga-FAPI PET/CT

IgG4-related Disease

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
Peking Union Medical College Hospital

Recruiting

FAPI-PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

China
Peking Union Medical College Hospital

Recruiting

Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT

Arthritis

China
Jonsson Comprehensive Cancer Center

Completed

Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective

Neuroendocrine Tumors

United States
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Peking Union Medical College Hospital

Unknown

Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT

Inflammatory Bowel Disease

China
Peking Union Medical College Hospital

Unknown

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Unknown

Characterizing SAPHO With 68Ga-FAPI PET/CT

SAPHO Syndrome

China
Peking Union Medical College Hospital

Recruiting

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Lung Neoplasms

China
Peking University First Hospital

Recruiting

68Ga-P3 PET/CT Imaging in Prostate

Neoplasms

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Glioma

China
RenJi Hospital

Recruiting

Trop2-targeted immunoPET Imaging of Solid Tumors

Cervical Cancer | Head and Neck Cancer | Nasopharyngeal Cancer | Ovarian Cancer | Lung Cancer | Solid Tumor | Prostate Cancer | Cholangiocarcinoma | Bladder Cancer | Endometrial Cancer | Thyroid Cancer | Liver Cancer | Solid Carcinoma | Uroepithelial Carcinoma

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT

Ankylosing Spondylitis | Spondyloarthritis | Axial Spondyloarthritis

China
Ipsen

Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Gastro-Enteropancreatic Neuroendocrine Tumor

United States, Austria, Denmark
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction (GRGDMI)

Coronary Artery Disease

China
Peking Union Medical College Hospital
Beijing Tiantan Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (GRGDG)

Glioma

China
First Affiliated Hospital of Fujian Medical University

Recruiting

[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors

Bone Metastases | Bone Tumor

China
RenJi Hospital

Recruiting

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

Ovarian Cancer | Epithelial Ovarian Cancer | Positron Emission Tomography | 68Ga-FAPI

China
Affiliated Hospital of Jiangnan University

Recruiting

68Ga-labeled NY105 PET Imaging in Patients

Cancer

China
First Affiliated Hospital of Fujian Medical University

Recruiting

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Lymphoma | Leukemia | Multiple Myeloma

China
RenJi Hospital

Recruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

Stomach Cancer | Pancreatic Cancer | Small Intestine Cancer | Digestive System Carcinoma | Colon Cancer | Liver Cancer | Digestive System Neoplasm | Gallbladder Carcinoma | Malignancy | Appendix Cancer | Esophagus Cancer | Rectum Cancer | Digestive Cancer | Digestive System Cancer | Bile Duct Carcinoma

China
Wuhan Union Hospital, China

Recruiting

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Malignant Neoplasm

China
RenJi Hospital

Recruiting

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer

Lung Diseases | Lung Neoplasms | Lung Cancer | Lung Cancer Metastatic | Lung Inflammation

China
Peking Union Medical College Hospital

Recruiting

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

Colorectal Cancer

China

Search clinical trials for: [68Ga]-NeoB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations